Adenovirus 5 vector genetically re-targeted by an Affibody molecule with specificity for tumor antigen HER2/neu
2007 · Cancer Gene Therapy · 46 citations
https://doi.org/10.1038/sj.cgt.7701027
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
391
Citations
9
h-index
9
i10-index
Susanna Myhre is an academic researcher from AstraZeneca (Sweden). The author has contributed to research in topics: Virus-based gene therapy research & Viral Infectious Diseases and Gene Expression in Insects & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 9, co-authored 13 publications.
Click to start Chat